tiprankstipranks
Trending News
More News >
Evogene (EVGN)
NASDAQ:EVGN
US Market

Evogene (EVGN) Financial Statements

Compare
641 Followers

Evogene Financial Overview

Evogene's market cap is currently $7.38M. The company's EPS TTM is $-0.609; its P/E ratio is -0.45; Evogene is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.85M$ 8.51M$ 5.64M$ 1.68M$ 930.00K
Gross Profit$ 795.00K$ 3.39M$ 1.40M$ -1.77M$ -2.07M
Operating Income$ -14.00M$ -21.73M$ -26.39M$ -29.71M$ -31.49M
EBITDA$ -12.85M$ -15.38M$ -23.20M$ -26.93M$ -27.80M
Net Income$ -8.48M$ -16.48M$ -23.88M$ -26.64M$ -27.79M
Balance Sheet
Cash & Short-Term Investments$ 12.99M$ 15.31M$ 31.06M$ 35.35M$ 53.87M
Total Assets$ 20.05M$ 39.86M$ 51.10M$ 56.13M$ 76.30M
Total Debt$ 2.20M$ 12.87M$ 11.51M$ 11.93M$ 2.67M
Net Debt$ -10.76M$ -2.43M$ -9.27M$ -17.05M$ -29.66M
Total Liabilities$ 5.00M$ 25.03M$ 22.42M$ 21.34M$ 12.88M
Stockholders' Equity$ -82.00K$ -1.45M$ 12.05M$ 27.93M$ 53.65M
Cash Flow
Free Cash Flow$ -13.64M$ -20.33M$ -22.36M$ -24.85M$ -25.56M
Operating Cash Flow$ -13.50M$ -19.70M$ -21.58M$ -23.68M$ -24.84M
Investing Cash Flow$ 17.74M$ 9.62M$ -4.54M$ 13.27M$ -20.44M
Financing Cash Flow$ -6.60M$ 4.66M$ 18.15M$ 9.34M$ 30.28M
Currency in USD

Evogene Earnings and Revenue History

Evogene Debt to Assets

Evogene Cash Flow

Evogene Forecast EPS vs Actual EPS